The goal of this clinical trial is to explore the diagnostic efficacy of detachable string magnetically controlled capsule endoscopy (ds-MCE) for identification of bleeding lesions in patients with antiplatelet drugs-related acute non-hematochezia gastrointestinal bleeding. The main questions it aims to answer are:
Compared to the conventional esophagogastroduodenoscopy, does ds-MCE accurately detect bleeding lesions in the upper gastrointestinal tract in patients with antiplatelet drugs-related acute non-hematochezia gastrointestinal bleeding? Recording bleeding lesions in the small bowel detected by ds-MCE in patients with antiplatelet drugs-related acute non-hematochezia gastrointestinal bleeding.
Participants will:
Undergo ds-MCE first and subsequently EGD within 24 hours. Receive follow-up in the following 30days.
No gender limit, age ≥ 18 years；
Acute non-hematochezia gastrointestinal bleeding symptoms, including haematemesis or melena；
Taking antiplatelet drugs continuously for at least 14 days；
Hemodynamically stable；
Age < 18 years；
Hemodynamically unstable even after initial volume resuscitation and/or have ongoing fresh hematemesis at presentation；
With upper gastrointestinal bleeding caused by peptic ulcer or acute gastric mucosal lesion within 1 month before inclusion；
History of endoscopic therapy (such as ESD, EMR, etc.) within 1 month before inclusion；
Changhai Hospital
Lead sponsor
First Affiliated Hospital Xi'an Jiaotong University
Collaborator
Qilu Hospital of Shandong University
Collaborator